KWF
Lead4Life PPP Call — Lead-212 Radiopharmaceuticals
Call opens 5 May 2026; submission deadline not yet specified
Last verified:
Details
| Funder | KWF |
| Budget | €500k–€2M per project; total €5M |
| Deadline | 5 May 2026 |
| Consortium | Required — public-private partnership (PPP) collaboration required |
| Application | Single stage (open competitive selection via KWF GMS) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
PPP call for projects strengthening Pb-212 production/supply chain or enabling technologies for clinical application of Pb-212-based radiopharmaceuticals. Proposals must involve public-private collaboration and be submitted through KWF GMS; projects are embedded in a national TRT innovation network. Clinical trials and full therapeutic product development are out of scope.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Lead4Life PPP Call
Deadline: 5 May 2026€5,000,000Lead4life Ppp Call 2026
Deadline: 5 May 2026Lead4Life PPP Call — Lead-212 Production & Supply Chain and Enabling Technologies
Deadline: 5 May 2026€500k–€2M per project; total budget €5MKWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATProof Of Concept 2026-2
Deadline: 2 Jun 2026
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free